Structure–Activity Relationships and Molecular Pharmacology of Positive Allosteric Modulators of the Mu-Opioid Receptor DOI
Mengchu Li,

Xinmin Gan,

Kun Liu

и другие.

ACS Chemical Neuroscience, Год журнала: 2024, Номер 16(1), С. 16 - 29

Опубликована: Дек. 11, 2024

Positive allosteric modulation of the mu-opioid receptor is a promising strategy to address ever-growing problem acute and chronic pain management. modulators (PAMs) could be employed enhance efficacy endogenous opioid peptides degree that provides relief without need for traditional drugs. Alternatively, PAMs might used action drugs so provide an opioid-sparing effect, allowing use lower doses agonists potentially decreasing associated side effects. BMS-986122 (2-(3-bromo-4-methoxyphenyl)-3-[(4-chlorophenyl)-sulfonyl]-thiazolidine) has been previously identified as PAM receptor. In present work, we have designed synthesized 33 analogs explore structure–activity relationships this scaffold confirm its mechanism action. Among several newly modulators, most compound (14b) had improved activity increase in vitro potency standard agonist DAMGO showed vivo mice antinociceptive morphine.

Язык: Английский

GPCR drug discovery: new agents, targets and indications DOI
José A. Lorente, Aleksandr V. Sokolov, Gavin Ferguson

и другие.

Nature Reviews Drug Discovery, Год журнала: 2025, Номер unknown

Опубликована: Март 3, 2025

Язык: Английский

Процитировано

2

Advances in the structural understanding of opioid allostery DOI Creative Commons
Nokomis Ramos‐Gonzalez, Balázs Varga, Susruta Majumdar

и другие.

Trends in Pharmacological Sciences, Год журнала: 2025, Номер unknown

Опубликована: Янв. 1, 2025

Activation of the μ opioid receptor (MOR) can give analgesia, but also has dangerous side effects. Drugs that target MOR through an allosteric site, meaning they bind outside usual pocket, present a novel mode activation with different pharmacology relative to orthosteric drugs. Recent structural studies valuable new information on how modulators interact MOR.

Язык: Английский

Процитировано

0

Molecular Glues: A New Approach to Modulating GPCR Signaling Bias DOI Creative Commons

Jamie Kushnir,

Ryan H. Gumpper

Biochemistry, Год журнала: 2025, Номер unknown

Опубликована: Фев. 3, 2025

G-protein-coupled receptors (GPCRs) transmit an extracellular chemical/biological signal across the cell membrane, stimulating array of intracellular signaling cascades. Canonically, these molecules bind to endogenous ligand pocket (orthosteric pocket), which stabilizes either active or inactive conformational ensemble receptor. However, recent structural evidence indicates that small can mediate protein–protein interactions between GPCR and their transducers. These are reminiscent molecular glues be powerful tools for modulating bias. In this Perspective, we will investigate current information available on how they modulate We also examine prospects drug/probe design.

Язык: Английский

Процитировано

0

Dynamic chemical modifications and chemical interventions of G protein-coupled receptor DOI
Ping Xu, Jingying Hu, Yuting Gao

и другие.

Scientia Sinica Chimica, Год журнала: 2025, Номер unknown

Опубликована: Фев. 1, 2025

Язык: Английский

Процитировано

0

Affinity-based DEL Selections with Different Target Types: Overview and Achievements DOI Open Access
Qiuxia Chen, David I. Israel

Royal Society of Chemistry eBooks, Год журнала: 2025, Номер unknown, С. 1 - 16

Опубликована: Фев. 21, 2025

DNA-encoded library (DEL) selection is typically an affinity-based process that encompasses the incubation of DELs with a target, separation compounds bind target from those do not bind, amplification and sequencing DNA barcodes, decoding to reveal chemical structures binders. DEL technology has had notable impact in drug discovery various projects progressing into different stages development clinical trials. methodology allows for ultra-high throughput screening, permitting exploration broad diversity rapid identification hits exhibit desired effects specific targets. have been successfully employed small molecules targeting variety pharmaceutical targets, including proteins nucleic acids. This approach expedited tool probe biological processes hit progressed candidates, thereby facilitating process. In this chapter, we provide overview affinity strategies achievements selections on types.

Язык: Английский

Процитировано

0

Opioid crisis: compound opens up potential strategy to tackle overdoses DOI
Catherine M. Cahill

Nature, Год журнала: 2024, Номер 631(8021), С. 512 - 513

Опубликована: Июль 3, 2024

Язык: Английский

Процитировано

1

Challenges and Prospects of DNA-Encoded Library Data Interpretation DOI
Moreno Wichert, Laura Guasch, Raphael M. Franzini

и другие.

Chemical Reviews, Год журнала: 2024, Номер 124(22), С. 12551 - 12572

Опубликована: Ноя. 7, 2024

DNA-encoded library (DEL) technology is a powerful platform for the efficient identification of novel chemical matter in early drug discovery process enabled by parallel screening vast libraries encoded small molecules through affinity selection and deep sequencing. While DEL selections provide rich data sets computational discovery, underlying technical factors influencing remain incompletely understood. This review systematically examines key parameters affecting information their impact on hit triaging machine learning integration. The need rigorous handling interpretation emphasized, with standardized methods being critical success DEL-based approaches. Major challenges include relationship between sequence counts binding affinities, frequent hitters, influence such as inhomogeneous composition, DNA damage, linkers modes. Experimental artifacts, those caused protein immobilization matrix effects, further complicate interpretation. Recent advancements using to denoise predict candidates are highlighted. offers practical guidance adopting best practices integrating robust methodologies, comprehensive analysis, tools improve accuracy efficacy DEL-driven discovery.

Язык: Английский

Процитировано

1

Opioid antidote gets a boost DOI
Sarah Crunkhorn

Nature Reviews Drug Discovery, Год журнала: 2024, Номер 23(9), С. 658 - 658

Опубликована: Июль 25, 2024

Процитировано

0

Enhancing naloxone DOI
John F. Foley

Science Signaling, Год журнала: 2024, Номер 17(847)

Опубликована: Июль 30, 2024

A negative allosteric modulator of the μ-opioid receptor enhances efficacy naloxone.

Язык: Английский

Процитировано

0

De novo Design of A Fusion Protein Tool for GPCR Research DOI
Kaixuan Gao, Xin Zhang, Jia Nie

и другие.

bioRxiv (Cold Spring Harbor Laboratory), Год журнала: 2024, Номер unknown

Опубликована: Сен. 15, 2024

Abstract G protein-coupled receptors (GPCRs) play pivotal roles in cellular signaling and represent prominent drug targets. Structural elucidation of GPCRs is crucial for discovery efforts. However, structural studies remain challenging, particularly inactive state structures, which often require extensive protein engineering. Here, we present a de novo design strategy termed “click fusion” generating fusion proteins to facilitate GPCR studies. Our method involves the rational structurally stable domains rigidly linked GPCRs. The resulting enhances thermostability target aids determining structures via cryo-electron microscopy (cryo-EM). We further demonstrate that designed can be transferred among similar with minor adjustments linker region. study introduces promising approach facilitating advancing

Язык: Английский

Процитировано

0